(Q83367527)
Statements
Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors (English)
Joseph P Boni
Patricia Martins
Susan E Quinn
Charles Zacharchuk
Peter Amorusi
Eric K Rowinsky